These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8962169)

  • 1. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Langman LJ; LeGatt DF
    Transplant Proc; 1996 Dec; 28(6):3013-5. PubMed ID: 8962169
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downstream consequences of calcineurin inhibition.
    Batiuk TD; Halloran PF
    Transplant Proc; 1997; 29(1-2):1239-40. PubMed ID: 9123289
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of immunosuppressive drugs in transplantation.
    Triemer H
    J Med Assoc Ga; 1998 Apr; 87(2):93-6. PubMed ID: 16259250
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
    Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
    Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
    [No Abstract]   [Full Text] [Related]  

  • 6. ATP-binding cassette transporters and calcineurin inhibitors: potential clinical implications.
    van Gelder T; Klupp J; Sawamoto T; Christians U; Morris RE
    Transplant Proc; 2001 May; 33(3):2420-1. PubMed ID: 11377580
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacodynamic monitoring of immunosuppressive drugs.
    Yatscoff RW; Aspeslet LJ; Gallant HL
    Clin Chem; 1998 Feb; 44(2):428-32. PubMed ID: 9474055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A new immunosuppressor: CellCept].
    Mouly-Bandini A
    Presse Med; 2001 Jan; 30(2):66-7. PubMed ID: 11244816
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview of transplantation immunology and the pharmacotherapy of adult solid organ transplant recipients: focus on immunosuppression.
    Bush WW
    AACN Clin Issues; 1999 May; 10(2):253-69; quiz 304-6. PubMed ID: 10578712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil monitoring: is there evidence that it can improve outcomes?
    Byrne R; Yost SE; Kaplan B
    Clin Pharmacol Ther; 2011 Aug; 90(2):204-6. PubMed ID: 21772295
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunocompetence assay for net effect of combined immunosuppression.
    Nagashima N; Shalabi A; Watanabe T; Ogawa N; Koyama I; Kyo S; Burdick JF
    Transplant Proc; 2001 May; 33(3):2350-1. PubMed ID: 11377556
    [No Abstract]   [Full Text] [Related]  

  • 13. FK506 in bone marrow transplantation.
    Hemenway C
    Blood; 1995 Nov; 86(9):3611-2. PubMed ID: 7579473
    [No Abstract]   [Full Text] [Related]  

  • 14. [Review of a new immunosuppressive drug: enteric-coated mycophenolate sodium (Myfortic)].
    Sánchez-Fructuoso AI
    Nefrologia; 2005; 25(3):234-42, 244. PubMed ID: 16053004
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants.
    Mueller XM
    Ann Thorac Surg; 2004 Jan; 77(1):354-62. PubMed ID: 14726104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monitoring of immunosuppressive drugs: a pharmacodynamic approach.
    Yatscoff RW; Aspeslet LJ
    Ther Drug Monit; 1998 Oct; 20(5):459-63. PubMed ID: 9780118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil as induction therapy after liver transplantation.
    McDiarmid SV
    Liver Transpl Surg; 1999 Jul; 5(4 Suppl 1):S85-9. PubMed ID: 10431021
    [No Abstract]   [Full Text] [Related]  

  • 19. [FK506 and kifunensine, new immunomodulators of microbial origin].
    Izumi S; Okuhara M
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1800-12. PubMed ID: 7692469
    [No Abstract]   [Full Text] [Related]  

  • 20. Mycophenolate mofetil, Cellcept, a new immunosuppressive drug with great potential in internal medicine.
    Smak Gregoor PJ; van Gelder T; Weimar W
    Neth J Med; 2000 Dec; 57(6):233-46. PubMed ID: 11099793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.